Inverness’ Wampole Labs Adds Rapid HIV Test To Point-Of-Care Offerings
This article was originally published in The Gray Sheet
Executive Summary
Wampole will compete with Orasure in the physician office and point-of-care (PoC) rapid HIV testing market under an exclusive U.S. distribution pact with Efoora for its Rapid HIV test
You may also be interested in...
Inverness’ $92.5 Mil. Abbott Rapid Testing Buy Could Return TestPack To U.S.
Abbott Labs will retain exclusive distribution rights for the TestPack and Signify test lines in the U.S., while the products' new owner - Inverness Medical Innovations - will take on international distribution responsibilities
Inverness’ $92.5 Mil. Abbott Rapid Testing Buy Could Return TestPack To U.S.
Abbott Labs will retain exclusive distribution rights for the TestPack and Signify test lines in the U.S., while the products' new owner - Inverness Medical Innovations - will take on international distribution responsibilities
Inverness Expands Diagnostics Focus To Cardiac R&D
Inverness Medical Innovations plans to initiate a cardiac diagnostics portfolio with a home-use prothrombin test launch at the end of 2004